SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Outlook Therapeutics, ...

Outlook Therapeutics, Inc. (OTLK) Investor Notice: Robbins LLP Reminds Investors of Class Action Filed Against Outlook Therapeutics, Inc. Robbins LLP reminds investors that a shareholder filed a class ...

SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Outlook Therapeutics, Inc. (NASDAQ: OTLK) securities between December 29, 2022 and August 29, ...

Philadelphia, Pennsylvania--(Newsfile Corp. - November 29, 2023) - Berger Montague advises investors that a securities fraud class action lawsuit has been filed against Outlook Therapeutics, Inc.

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outlook Therapeutics, Inc. (NASDAQ: OTLK) between December 29, 2022 and August 29, 2023, both dates ...